NYSE:SLS - Galena Biopharma Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Galena Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $4.07 -0.21 (-4.91 %) (As of 12/9/2019 04:37 AM ET) Add Compare Today's Range$4.06Now: $4.07▼$4.3850-Day Range$0.12MA: $2.71▼$6.1652-Week Range$3.67Now: $4.07▼$90.00Volume222,436 shsAverage Volume246,613 shsMarket Capitalization$19.83 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Develop biopharmaceuticals Industry, Sector and Symbol Stock Exchange NYSE Industry Biotechnology Sub-IndustryN/A SectorHealth Technology Current SymbolNYSE:SLS Previous Symbol CUSIPN/A CIK1392577 WebN/A Phone(917) 438-4353Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares4,872,000Market Cap$19.83 million Next Earnings Date3/27/2020 (Estimated) OptionableNot Optionable Receive SLS News and Ratings via Email Sign-up to receive the latest news and ratings for SLS and its competitors with MarketBeat's FREE daily newsletter. SLS Rates by TradingView Galena Biopharma (NYSE:SLS) Frequently Asked Questions What is Galena Biopharma's stock symbol? Galena Biopharma trades on the New York Stock Exchange (NYSE) under the ticker symbol "SLS." When is Galena Biopharma's next earnings date? Galena Biopharma is scheduled to release their next quarterly earnings announcement on Friday, March 27th 2020. View Earnings Estimates for Galena Biopharma. Has Galena Biopharma been receiving favorable news coverage? News headlines about SLS stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Galena Biopharma earned a news sentiment score of -1.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Galena Biopharma. Who are some of Galena Biopharma's key competitors? Some companies that are related to Galena Biopharma include Circassia Pharmaceuticals (CIR), Botanix Pharmaceuticals (BOT), Burcon NutraScience (BU), Novoheart (NVH), Orthocell (OCC), Medicure (MPH), Medlab Clinical (MDC), 4d Pharma (DDDD), Equillium (EQ), Ampio Pharmaceuticals (AMPE), Pediapharm (PDP), IntelGenx Technologies (IGX), Tiziana Life Sciences (TILS), Bionomics (BNO) and Promis Neurosciences (PMN). What other stocks do shareholders of Galena Biopharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Galena Biopharma investors own include Nabriva Therapeutics (NBRV), Novavax (NVAX), SenesTech (SNES), Taronis Technologies (TRNX), Allena Pharmaceuticals (ALNA), Ameri (AMRH), Aytu Bioscience (AYTU), ConforMIS (CFMS), CHF Solutions (CHFS) and Crispr Therapeutics (CRSP). Who are Galena Biopharma's key executives? Galena Biopharma's management team includes the folowing people: Angelos M. Stergiou, President, Chief Executive Officer & DirectorAleksey N. Krylov, Chief Financial Officer, Treasurer & DirectorNicholas J. Sarlis, Director, Chief Medical Officer & Senior VPBarbara A. Wood, Secretary, Executive VP & General CounselGregory M. Torre, Director, Chief Regulatory Officer & Senior VP How do I buy shares of Galena Biopharma? Shares of SLS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Galena Biopharma's stock price today? One share of SLS stock can currently be purchased for approximately $4.07. How big of a company is Galena Biopharma? Galena Biopharma has a market capitalization of $19.83 million. View Additional Information About Galena Biopharma. How can I contact Galena Biopharma? The company can be reached via phone at (917) 438-4353. MarketBeat Community Rating for Galena Biopharma (NYSE SLS)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 103 (Vote Outperform)Underperform Votes: 114 (Vote Underperform)Total Votes: 217MarketBeat's community ratings are surveys of what our community members think about Galena Biopharma and other stocks. Vote "Outperform" if you believe SLS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SLS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/9/2019 by MarketBeat.com StaffFeatured Article: Why Invest in Dividend Achievers?
